...
首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >Anti-Mullerian hormone levels after laparoscopic cystectomy for endometriomas as a possible predictor for pregnancy in infertility treatments
【24h】

Anti-Mullerian hormone levels after laparoscopic cystectomy for endometriomas as a possible predictor for pregnancy in infertility treatments

机译:子宫内膜瘤的腹腔镜膀胱切除术后抗穆勒激素水平可能是不育治疗中怀孕的可能指标

获取原文
获取原文并翻译 | 示例

摘要

We assessed the associations between preoperative and postoperative serum anti-Mullerian hormone (AMH) levels and parameters of endometriosis and endometriomas surgery with the success of infertility treatments after cystectomy. Seventeen out of 54 patients got pregnant during the infertility treatments. In these patients, the median interval from surgery to conception was 16.3 months. The serum AMH levels 1-year postoperatively were significantly higher in the pregnant group compared to the non-pregnant group (3.44 +/- 1.78 versus 2.17 +/- 2.24 ng/ml, p = 0.049). The median interval from surgery to recurrence was 34.4 months, and no significant differences were found in the serum AMH levels at any time point between the recurrence and non-recurrence groups. Serum AMH levels 1 year after laparoscopic cystectomy for endometriomas may predict the success of postoperative infertility treatments, but not a recurrence of endometriomas.
机译:我们评估了术前和术后血清抗Mullerian激素(AMH)水平与子宫内膜异位和子宫内膜瘤手术参数与膀胱切除术后不育治疗成功之间的关联。 54名患者中有17名在不育治疗期间怀孕。在这些患者中,从手术到受孕的平均间隔为16.3个月。与非妊娠组相比,妊娠组术后1年的血清AMH水平显着更高(3.44 +/- 1.78 ng对2.17 +/- 2.24 ng / ml,p = 0.049)。从手术到复发的中位间隔为34.4个月,在复发和非复发组之间的任何时间点,血清AMH水平均无显着差异。腹腔镜膀胱切除术治疗子宫内膜异位症一年后的血清AMH水平可能预示了术后不育治疗的成功,但子宫内膜异位症并未复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号